Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis
Pathogens · 2025
DOI: 10.3390/pathogens14111146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Cristina Cigana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infections and Cystic Fibrosis Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Sphingosine-1-Phosphate Receptors, Pseudomonas Infections. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione per la Ricerca sulla Fibrosi Cistica, Italian CF Research Foundation.
Abstract (Originalsprache)
Background
Pseudomonas aeruginosa infection is a major driver of morbidity and mortality in cystic fibrosis (CF), yet disease severity varies widely among people with CF (pwCF). This clinical heterogeneity suggests the involvement of host genetic modifiers beyond CFTR. We previously identified sphingosine 1-phosphate receptor 1 (S1PR1) as a candidate gene associated with susceptibility to P. aeruginosa. Here, we investigated its role in modulating airway epithelial responses to infection.
Methods
Using CRISPR/Cas9, we generated S1PR1-knockout bronchial epithelial cells with (IB3-1) and without (C38) CFTR mutations. We assessed cell viability, cytotoxicity, and interleukin-8 secretion following exposure to P. aeruginosa exoproducts. S1PR1 protein expression was evaluated in lung tissue from pwCF and non-CF individuals using immunohistochemistry.
Results
S1PR1-mutant cells produced truncated, non-functional peptides. In CFTR-mutant cells, S1PR1 loss reduced viability, increased cytotoxicity, and significantly enhanced interleukin-8 production in response to P. aeruginosa exoproducts. These effects were not observed in CFTR-competent cells. Notably, S1PR1 protein levels were markedly lower in lung tissue from pwCF compared to non-CF individuals.
Conclusions
S1PR1 deficiency exacerbates epithelial damage and inflammatory responses to P. aeruginosa in CF models. These findings highlight S1PR1 as a potential contributor to infection severity and a promising target for therapeutic strategies in pwCF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infections and Cystic Fibrosis Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- Vita-Salute San Raffaele University, 20132 Milan, Italy.
ORCID-Profile: Cristina Cigana, Laura Veschetti, Nicola Ivan Lorè
Förderung
- Fondazione per la Ricerca sulla Fibrosi Cistica
- Italian CF Research Foundation
Zitieren
APA
Cigana, C., Caslini, C., Migliara, A., Alcala'-Franco, B., Veschetti, L., Lorè, N. I., Lombardo, A., & Bragonzi, A. (2025). Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis. Pathogens. https://doi.org/10.3390/pathogens14111146
Vancouver
Cigana C, Caslini C, Migliara A, Alcala'-Franco B, Veschetti L, Lorè NI, et al. Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis. Pathogens. 2025. doi:10.3390/pathogens14111146
BibTeX
@article{Cigana2025,
author = {Cigana, Cristina and Caslini, Claudia and Migliara, Alessandro and Alcala'-Franco, Beatriz and Veschetti, Laura and Lorè, Nicola Ivan and Lombardo, Angelo and Bragonzi, Alessandra},
title = {Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14111146}
}
EUVIMED